导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 20.58% | 750/4927 |
| 近一周 | -1.37% | 992/5356 |
| 近一月 | -7.79% | 4508/5364 |
| 近一季 | -18.77% | 4483/5299 |
| 近半年 | 19.87% | 565/5076 |
| 近一年 | 26.51% | 734/4680 |
| 近两年 | 108.57% | 752/4157 |
| 近三年 | 53.08% | 997/3623 |
| 成立以来 | 211.18% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.33% 3880/5130 |
84.97% 339/5464 |
- - |
- - |
| 2025 | 36.77% 1695/5130 |
-4.86% 4453/4624 |
-1.55% 3757/4802 |
47.13% 468/4970 |
-0.75% 2191/5130 |
| 2024 | -2.09% 2917/4618 |
-10.75% 3637/4340 |
-2.34% 2229/4442 |
8.86% 2722/4550 |
3.19% 849/4618 |
| 2023 | -16.25% 2089/4216 |
5.02% 997/3759 |
-2.65% 1348/3909 |
-14.24% 3262/4055 |
-4.48% 1866/4209 |
| 2022 | -26.15% 1957/3578 |
-16.60% 1179/2804 |
-0.43% 2624/3205 |
-12.25% 1625/3430 |
1.35% 1216/3570 |
| 2021 | 10.83% 598/2717 |
-11.47% 1522/1745 |
35.81% 45/2232 |
-6.71% 1406/2560 |
-1.19% 1742/2708 |
| 2020 | 56.26% 506/1596 |
1.24% 322/1036 |
31.83% 200/1256 |
0.29% 1167/1472 |
16.74% 499/1690 |
| 2019 | 37.37% 459/926 |
24.31% 1010/3054 |
-3.93% 2367/3201 |
7.56% 352/939 |
6.94% 654/1014 |
| 2018 | -28.85% 403/668 |
- - |
- - |
- - |
-12.53% 2440/2977 |
| 2017 | -2.62% 405/531 |
- - |
- - |
- - |
- - |
| 2016 | -28.51% 395/455 |
- - |
- - |
- - |
- - |
| 2015 | 92.77% 14/433 |
- - |
- - |
- - |
- - |
| 2014 | 39.48% 63/432 |
- - |
- - |
- - |
- - |
| 2013 | 33.83% 49/398 |
- - |
- - |
- - |
- - |
| 2012 | 3.40% 267/459 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合A | 1.0196 | 49.11% |
| 招商品质成长混合C | 0.9797 | 48.85% |
| 招商创新增长混合A | 1.0526 | 48.59% |
| 招商创新增长混合C | 1.0013 | 48.30% |
| 华泰柏瑞医疗健康A | 2.5834 | 44.36% |
| 华泰柏瑞医疗健康C | 2.5230 | 44.21% |
| 大摩优悦安和混合A | 0.8851 | 43.59% |
| 大摩优悦安和混合C | 0.8688 | 43.46% |
| 西部利得数字产业混合C | 1.6965 | 32.33% |
| 中信建投医药健康C | 0.7284 | 31.85% |
| 华商价值精选混合 VS. 长安宏观策略混合A(740001) |